Latest News

New drugs offer hope for migraine prevention

Two new studies may offer hope for people with migraines. Both studies involve drugs that are aimed at preventing migraine attacks from occurring, rather than stopping the attacks once they have started. These studies are the first to test monoclonal antibodies for the prevention of migraine, and both are directed against a relatively new target in migraine prevention, the calcitonin gene-related peptide, or CGRP. CGRP has been thought to be important in migraine, but never have drugs been developed to specifically target the protein.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Microexons: Small fragments of genes, essential for neuron maturation

  • Insomnia can predict the appearance of back pain in adults

  • Parkinson's: Small molecules researched for the regeneration of dopaminergic neurons

  • Why some antidepressants may initially worsen symptoms

  • Autism, intellectual disability studied in quest for new treatment approaches

  • Tackling neurotransmission precision

  • Of bugs and brains: Striking similarities in brain structures across invertebrates

  • Neuro-oncologists discover cancer cells can burn acetate for fuel

  • Parkinson's disease reverted at experimental stage

  • The dementia that is not Alzheimer's disease

  •